Four-factor Prothrombin Complex Concentrate Use for Bleeding Management in Adult Trauma

被引:0
|
作者
Mora, Lidia [1 ]
Maegele, Marc [2 ]
Grottke, Oliver [3 ]
Koster, Andreas [4 ,5 ]
Stein, Philipp [6 ]
Levy, Jerrold H. [7 ]
Erdoes, Gabor [8 ]
机构
[1] Autonomous Univ Barcelona, Vall dHebron Trauma Rehabil & Burns Hosp, Dept Anaesthesiol Intens Care & Pain Clin, Barcelona, Spain
[2] Witten Herdecke Univ, Cologne Merheim Med Ctr, Dept Trauma & Orthoped Surg, Campus Cologne Merheim, Cologne, Germany
[3] Rhenish Westphalian Tech Univ, Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany
[4] Sana Heart Ctr Cottbus, Clin Anesthesiol & Interdisciplinary Intens Care M, Cottbus, Germany
[5] Ruhr Univ Bochum, Bochum, Germany
[6] Kantons Spital St Gallen, Div Anesthesiol, Hosp Linth, St Gallen, Switzerland
[7] Duke Univ, Sch Med, Dept Anesthesiol Crit Care & Surg, Durham, NC USA
[8] Univ Bern, Bern Univ Hosp, Dept Anesthesiol & Pain Med, Inselspital, Bern, Switzerland
关键词
K ANTAGONIST REVERSAL; INDUCED COAGULOPATHY; ORAL ANTICOAGULANTS; THROMBIN GENERATION; ANDEXANET ALPHA; OPEN-LABEL; PLASMA; TRANSFUSION; COAGULATION; SURGERY;
D O I
10.1097/ALN.0000000000005230
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:351 / 363
页数:13
相关论文
共 50 条
  • [41] Fibrinogen and prothrombin complex concentrate in trauma coagulopathy
    Hannon, Matthew
    Quail, Jacob
    Johnson, Matthew
    Pugliese, Cara
    Chen, Kejian
    Shorter, Heidi
    Riffenburgh, Robert
    Jackson, Ronald
    JOURNAL OF SURGICAL RESEARCH, 2015, 196 (02) : 368 - 372
  • [42] Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retrospective Cohort Study
    Kiskaddon, Amy L.
    Goldenberg, Neil A.
    Fierstein, Jamie L.
    Miller, Alexandra
    Quintessenza, James A.
    Kartha, Vyas M.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (06) : 873 - 882
  • [43] Emergency intensive care unit pharmacist's intervention may reduce time to four-factor prothrombin complex concentrate administration: a retrospective study
    Imanaka, Shoichi
    Kuwabara, Tatsuro
    Ikeda, Hiroto
    Miyake, Yasufumi
    Enomoto, Hiromi
    Sakamoto, Tetsuya
    Yasuno, Nobuhiro
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2020, 6 (01)
  • [44] Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal
    Zemrak, Wesley
    Manuel, Francis
    Smith, Kathryn E.
    Rolfe, Stephen
    Hayes, Timothy
    Trowbridge, Robert L.
    Carlone, Brian
    Seder, David
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (02) : 263 - 271
  • [45] Modelling the effects of 4-factor prothrombin complex concentrate for the management of factor Xa-associated bleeding
    Muir, Ineke
    Herzog, Eva
    Brechmann, Markus
    Ghobrial, Oliver
    Rezvani Sharif, Alireza
    Hoffman, Maureane
    PLOS ONE, 2024, 19 (09):
  • [46] Four-Factor Prothrombin Complex Concentrate in Left Ventricular Assist Device Implantation: Inverse Propensity Score-Weighted Analysis
    Monaco, Fabrizio
    Licheri, Margherita
    Barucco, Gaia
    De Bonis, Michele
    Lapenna, Elisabetta
    Pieri, Marina
    Zangrillo, Alberto
    Ortalda, Alessandro
    ASAIO JOURNAL, 2023, 69 (07) : E293 - E300
  • [47] Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance Review
    Milling, Truman J.
    Voronov, Anna
    Schmidt, Dirk S.
    Lindhoff-Last, Edelgard
    THROMBOSIS AND HAEMOSTASIS, 2025, 125 (01) : 46 - 57
  • [48] Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis
    Piran, Siavash
    Khatib, Rasha
    Schulman, Sam
    Majeed, Ammar
    Holbrook, Anne
    Witt, Daniel M.
    Wiercioch, Wojtek
    Schunemann, Holger J.
    Nieuwlaat, Robby
    BLOOD ADVANCES, 2019, 3 (02) : 158 - 167
  • [49] Low-dose versus standard-dose four-factor prothrombin complex concentrate for factor-Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage
    Cascone, Ava E.
    Daley, Mitchell J.
    Pan, Neil
    Padilla-Tolentino, Eimeira
    Milling, Truman J.
    PHARMACOTHERAPY, 2021, 41 (06): : 501 - 507
  • [50] Pathogen safety of a pasteurized four-factor human prothrombin complex concentrate preparation using serial 20N virus filtration
    Nowak, Thomas
    Popp, Birgit
    Groener, Albrecht
    Schaefer, Wolfram
    Kalina, Uwe
    Enssle, Karlheinz
    Roth, Nathan J.
    TRANSFUSION, 2017, 57 (05) : 1184 - 1191